Publisher: Bentham Science Publishers
E-ISSN: 2212-3873|17|4|309-316
ISSN: 1871-5303
Source: Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.17, Iss.4, 2017-11, pp. : 309-316
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 16, Iss. 1, 2016-03 ,pp. :
Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 16, Iss. 3, 2017-01 ,pp. :
Experience with Remifentanil in Neonates and Infants
Drugs, Vol. 66, Iss. 10, 2006-01 ,pp. :
Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 16, Iss. 2, 2016-09 ,pp. :